Congenica secures new two-year contract with Hong Kong Genome Project
October 4, 2023
Congenica platform to continue providing tertiary analysis for Whole Genome Sequencing Cambridge, United Kingdom – Congenica, a digital health company providing software and solutions for the analysis and interpretation of genomic data at scale, today announces a two-year extension to their contract for the Hong Kong Genome Project (HKGP), the first large-scale genome sequencing initiative in [...]
Getinge completes acquisition of High Purity New England, Inc.
October 4, 2023
Getinge has today completed the previously announced acquisition of 100% of the shares in High Purity New England, Inc. On May 31, 2023, Getinge announced an agreement to acquire High Purity New England, Inc., a leading US-based company in the fast-growing areas of custom single-use solutions for bioprocessing applications. All conditions for the transaction and [...]
October 4, 2023
MIRO MGA systems enable fast, simultaneous trace gas analysis for Greenhouse Gases (GHGs) and pollutants for atmospheric and climate research, and industrial gas monitoring ZURICH -- Bruker Corporation (Nasdaq: BRKR) today announced a majority investment in MIRO Analytical AG, an innovative provider of fast, compact Quantum Cascade Laser (QCL)-based multi-gas analyzers for simultaneous, highest-precision monitoring of up [...]
Evonetix places first DNA synthesis development platform at Imperial College London
October 4, 2023
External placement marks a key milestone in the development of Evonetix’s benchtop DNA synthesis technology, in preparation for customer use and commercialization Cambridge, UK – EVONETIX LTD (‘Evonetix’), the Company developing semiconductor scale technology to improve access to gene synthesis, today announced its first placement of a DNA synthesis development platform for evaluation at Imperial College [...]
Synthego Bridges Critical Preclinical Gap to Accelerate CRISPR-based Cell and Gene Therapies
October 4, 2023
REDWOOD CITY, CA – Synthego, a leading provider of genome engineering solutions, has announced the launch of its IND-enabling (INDe) gRNAs, a transformative product offering that revolutionizes the CRISPR-based cell and gene therapy preclinical pipeline. This innovative offering empowers researchers with high-quality gRNAs designed specifically for GLP-regulated preclinical and IND-enabling studies, incorporating comprehensive IND-compliant materials and documentation [...]
October 4, 2023
Activates Standard BioTools’ strategy to unlock value in underserved portion of $100 billion industry Establishes leading platform of multi-omic technologies with the highest throughput and highest data quality to power clinical research insights Expands commercial reach with substantial cross-selling opportunities and complementary offerings Generates estimated $80 million of annual cost synergies by 2026 and enhanced combined path to profitability1 [...]
October 4, 2023
Carcinotech and CELLINK plan to revolutionize the drug discovery market by leveraging CELLINK’s bioprinting solutions and Carcinotech’s expertise in producing 3D bioprinted living tumors to provide protocols for users to develop cutting-edge cancer models. (Gothenburg, Sweden) Carcinotech and CELLINK are pleased to announce a collaborative partnership to develop and commercialize protocols for the biofabrication of [...]
ULVAC-PHI Launches Sales of Latest TOF-SIMS Instrument ‘PHI nanoTOF 3+’
October 4, 2023
Effortless automated measurement and high-quality data regardless of operator's skill Chigasaki, Japan -- ULVAC-PHI, Inc. has launched the sales of its flagship model of Time-of-Flight Secondary Ion Mass Spectrometry (TOF-SIMS) instrument, the 'PHI nanoTOF 3+.' Overview We are pleased to announce the launch of the PHI nanoTOF 3+. This new product release comes two years [...]
Telescope Innovations Product Deployed by 13 Pharma Giants in First Year
October 4, 2023
Vancouver, British Columbia --- Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies for the global pharmaceutical and chemical industries, is excited to announce that its flagship product for automated analysis of chemical reactions, Direct Inject Liquid Chromatography (DILCTM), is quickly being established in the market as a [...]
October 4, 2023
Fremont, California - SeqMatic, a leading provider of next-generation sequencing (NGS) and omics services, is proud to announce that it has received Visium Spatial Gene Expression and Visium Spatial Gene Expression for FFPE Certifications from 10x Genomics. These certifications further demonstrate SeqMatic's commitment to delivering efficient and professional solutions to its customers with single-cell and [...]

